Allopathic and complementary alternatives to hormone replacement therapy

Bibliography

• JONES KP: Menopause and cognitive function; estrogens and alternative therapies. Clin. Obstet. Gynecol (2000) 43(1):198–206.
   PubMedGoogle Scholar
• KRONENBERG F: Hot flashes: epidemiology and physiology. Ann. NY Acad. Sci. (1990) 592:52–86.
   PubMed Web of Science ®Google Scholar
• COOPE J, THOMPSON JM, OLLER L: Effects of 'natural oestrogen' replacement therapy on menopausal symptoms and blood clotting. Br. Med. J. (1975) 4:139–143.
   PubMed Web of Science ®Google Scholar
• SCHIFF I, TULCHINSKY D, CRAMER D, RYAN KJ: Oral medroxyprogesterone acetate in the treatment of postmenopausal symptoms. JAMA (1980) 244:1443–1445
   PubMed Web of Science ®Google Scholar
• ALBRECT BH, SCHIFF I, TULCHINSKY D, RYAN KJ: Objective evidence that placebo and oral medroxyprogesterone acetate diminish menopausal vasomotor flushes. Am. J. Obstet. Gynecol (1981) 139:631–635.
   PubMedGoogle Scholar
• RAY NE CHAN JK, THAMER M et al.: Medical expenditures for the treatment of osteoporotic fractures in the united states in 1995: report from the national osteoporosis foundation. I Bone. Miner. Res. (1997) 12(1):24–35.
   Google Scholar
• CONSESUS DEVELOPMENT CONFERENCE: Prophylaxis and treatment of osteoporosis. Am. J. Med. (1991) 90:107–110.
   PubMedGoogle Scholar
• NILAS L, CHRISTIANSEN C: Bone mass and its relationship to age and the menopause. J. Clin. Endocrinol Metab. (1987) 65:697–702.
   PubMed Web of Science ®Google Scholar
• GORSKY RD, KOPLAN JP, PETERSONHB et al.: Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis. Obstet. Gynecol (1994) 83(2):161–166.
   PubMedGoogle Scholar
• WALSH BW, SCHIFF I, ROSNER B: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl. J. Med. (1991) 325:1196–1204
   PubMed Web of Science ®Google Scholar
• THE WRITING GROUP FOR THE PEPI TRIAL: Effects of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA (1996) 275:370–375.
   PubMed Web of Science ®Google Scholar
• LOBO RA: Cardiovascular implications of estrogen replacement therapy. Obstet. Gynecol. (1990) 75(4):18S.
   PubMedGoogle Scholar
• SOOD AK, SOROSKY JI: Alternatives to estrogen replacement therapy in the menopausal patient. Partgrad. Obstet. Gynecol. (1996) 16(21):1–4.
   Google Scholar
• CARRANZA-LIRA S, CORTES-FUENTES E: Modification of vasomotor symptoms after various treatment modalities in the postmenopause. hat. J. Gynecol. Obstet. (2001) 73:169–171.
   Google Scholar
• STEARNS V, ISAACS C, ROWLAND J et al: A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors. Ann. Oncol. (2000) 11:17–22
   PubMed Web of Science ®Google Scholar
• LOPRINZI CL, SLOAN JA, PEREZ EA et al.: Phase III evaluation of fluoxetine for treatment of hot flashes. J. Clin. Oncol (2001) 6(15):1578–1583.
   Google Scholar
• GRADISHAR WJ, JORDAN VC: Clinical potential of new antiestrogens. Clin. Oncol. (1997) 15:840–852.
   Google Scholar
• MITLAK BH, COHEN FJ: In search of optimal long-term female hormone replacement: the potential of selective estrogen receptor modulators. Horm. Res. (1997) 48:155–163.
   PubMed Web of Science ®Google Scholar
• ETTINGER B, BLACK DM, MITLAK BH et al: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene results from a 3-year randomized clinical trial. "AMA (1999) 282:637–645.
   PubMed Web of Science ®Google Scholar
• BARRETT-CONNOR E, GRADY D, SASHEGYI A et al.: Raloxifene and cardiovascular events in osteoporotic postmenopausal women, four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. "AMA (2002) 287:847–857.
   Google Scholar
• COHEN FJ, WATTS S, SHAH A et al: Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60. Obstet. Gynecol (2000) 95:104–110.
   PubMed Web of Science ®Google Scholar
• DAVIES GC, HUSTER WJ, LU Y: Adverse events reported by postmenopausal women in controlled trials with raloxifene. Obstet. Gynecol (1999) 93:558–565.
   PubMed Web of Science ®Google Scholar
• FLEISCH H: Diphosphonates: history and mechanisms of action. Metab. Bone Dis. Relat. Res. (1981) 3:279–287.
   PubMedGoogle Scholar
• VAN ROOJEN N. Extracellular and intracellular action of clodronate in osteolytic bone diseases? A hypothesis. Cakil Tissue Int. (1993) 52:407–410.
   PubMedGoogle Scholar
• LIBERMAN UA, WEISS SR, BROLL J et al.: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl. J. Med. (1995) 333:1437–1443.
   PubMed Web of Science ®Google Scholar
• BLACK DM, CUMMINGS SR, KARPF DB et al: randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet (1996) 348:1535–1541.
   PubMed Web of Science ®Google Scholar
• GASS MLS, TAYLOR MB: Alternatives for women through menopause. Am. J. Obstet. Gynecol (2001) 185(2):547–556.
   Google Scholar
• MITKA M: FDA never promised an herb garden - but sellers and buyers eager to see new ones grow. "AMA (1998) 280:1554–1556.
   Google Scholar
• Use of botanicals for management of menopausal symptoms. ACOG Piaci Bull. (2001) 28:1–11.
   Google Scholar
• KASS-ANNESE B: Alternative therapies for menopause. Clin. Obstet. Gynecol. (2000) 43(1):162–183.
   PubMedGoogle Scholar
• SMITH IK: Hot flash relief. Time (2000) 156(3):82.
   PubMedGoogle Scholar
• EWIES AAA: A comprehensive approach to menopause; so far, one size should fit all. Obstet. Gynecol. Surv. (2001) 56(10):642–649.
   PubMedGoogle Scholar
• WADE C, KRONENBERG F, KELLY A et al.: Hormone Modulating Herbs; Implications for Women's Health." Am. Med. Women's Assoc. (1999) 54(4):181–183.
   Google Scholar
• DORNSTAUDER E, JISA E, UNTERRIEDER I et al.: Estrogenic activity of two standardized red clover extracts (Menoflavon) intended for large scale use in hormone replacement therapy.' Stec Biochem. Mol Biol. (2001) 78(1):67–75.
   Google Scholar
• MORITO K, HIROSE T, KINJO J et al.: Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol. Pharmaceut. Bull (2001) 24(4) 351–356.
   PubMed Web of Science ®Google Scholar
• LEIBERMAN S: A review of the effectiveness of Cimicifuga Racemosa [Black Cohoshl for the symptoms of menopause.' Women's Health (1998) 7(5):525–529.
   PubMedGoogle Scholar
• ALBERTAZZI P, PANSINI F, BONACCORSI G et al.: The effect of dietary soy supplementation on hot flushes. Obstet. Gynecol. (1998) 91:6–11.
   PubMed Web of Science ®Google Scholar
• HAN KK, SOARES JM, HAIDAR MA et al.: Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet. Gynecol (2002) 99(3):389–394.
   PubMed Web of Science ®Google Scholar
• ANDERSEN JW, JOHNSTONE BM, COOK-NEWELL ME: Meta-analysis of the effects of soy protein intake on serum lipids. N Engl. J. Med. (1995) 333:276–282.
   PubMedGoogle Scholar
• WILCOX G, WAHLQUIST ML, BURGER HG, MEDLEY G: Oestrogenic effects of plant foods in postmenopausal women. Br. Med. J. (1990) 301:905–906.
   PubMed Web of Science ®Google Scholar
• BAIRD DD, UMBACH DM, LANSDELL L et al.: Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J. Clin. Endocrinol. Metab. (1995) 80:1685–1690.
   PubMed Web of Science ®Google Scholar
• MURKIES AL, LOMBARD C, STRAUSS BJ et al.: Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas (1995) 21:189–195.
   PubMed Web of Science ®Google Scholar
• The Completed German Commission E Monographs: Therapeutic Guide To Herbal Medicines. Blumenthal M (ed.) American Botanical Council, Austin, Texas, USA (1998).
   Google Scholar
• MORRISSEY DR, KIRCHNER JT: Management of the climacteric. Postgrad. Med. (2000) 108(1):85–100.
   PubMed Web of Science ®Google Scholar
• CHENOY R, HUSSAIN S, TAYOB Y et al.: Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. Br. Med. J. (1994) 308:501–503.
   PubMed Web of Science ®Google Scholar
• O'HARA M, KIEFER D, FARRELL K, KEMPER K: A review of 12 commonly used medicinal herbs. Arch. Fam. Med. (1998) 7:523–536.
   PubMedGoogle Scholar
• TYLER VE: The Honest Herbal: A Sensible Guide To The Use Of Herbs And Related Remedies. 3rd ed. Pharmaceutical Products Press, Binghamtom, NY, USA (1993).
   Google Scholar
• MILLER K: Alternatives to estrogen for menopausal symptoms. Clin. Obstet. Gynecol. (1992) 35(4):884–891.
   PubMedGoogle Scholar
• MORRISSEY DR, KIRCHNER JT: Management of the climacteric. Postgrad. Med. (2000) 108(1):85–100.
   PubMed Web of Science ®Google Scholar